![](/img/cover-not-exists.png)
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
Koch, Till, Dahlke, Christine, Fathi, Anahita, Kupke, Alexandra, Krähling, Verena, Okba, Nisreen M A, Halwe, Sandro, Rohde, Cornelius, Eickmann, Markus, Volz, Asisa, Hesterkamp, Thomas, Jambrecina, AJournal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(20)30248-6
Date:
April, 2020
File:
PDF, 1.39 MB
2020